Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod.

Alessandro d'AmbrosioRocco CapuanoSettimio RossiAlvino BiseccoMichele LanzaCarlo GesualdoLetizia LeocaniMariaemma RodegherMassimo FilippiClara MarinoDavide MaimoneGioacchino TedeschiFrancesca SimonelliAntonio Gallo

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)

Initiation of FNG in MS is associated with a modest, not significant, increase in macular volume followed by no further significant changes over 2 years, highlighting the good safety profile of such treatment in MS.

Keyphrases

multiple sclerosis
optical coherence tomography
diabetic retinopathy
white matter
mass spectrometry
ms ms
combination therapy